Tag Archives: Taiho Oncology

Biologics by McKesson and AllianceRx Expand Specialty Pharmacy Oncology Offerings

INQOVI is for the treatment of adults with intermediate and high-risk myelodysplastic syndromes (MDS) including chronic myelomonocytic leukemia (CMML), two blood malignancies

Biologics by McKesson Expands Specialty Pharmacy Oncology Offerings

Biologics, as part of a recent reorganization, is now joining McKesson’s Provider Solutions business within the Pharmaceutical Solutions and Services (PSaS) business unit